Amylyx Pharmaceuticals Inc Sustainability Reports
Amylyx Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on developing and advancing novel therapies for neurodegenerative diseases and endocrine conditions.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00DP10YW1
1 reports from 2023 to 2023
Company Profile
Amylyx Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on developing and advancing novel therapies for neurodegenerative diseases and endocrine conditions.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
